Sms Pharmaceuticals Limited (NSE: Smspharma) Announces Broad-based Growth for Q1 FY27

SMS Pharmaceuticals Limited (NSE: SMSPHARMA) reports 6% YoY revenue growth in Q1 FY27, driven by high-value APIs and structural improvements.